Christine Richardson

Dr. Christine Richardson


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CRChristine Richardson
Christine Richardson
Shan YanShan Yan
Shan Yan
CVC. Greer Vestal
C. Greer Vestal
Reactive oxygen species (ROS) can be generated by defective endogenous reduction of oxygen by cellular enzymes or in the mitochondrial respiratory pathway, as well as by exogenous exposure to UV or environmental damaging agents. Regulation of intracellular ROS levels is critical since increases above normal concentrations lead to oxidative stress and DNA damage. A growing body of evidence indicates that the inability to regulate high levels of ROS leading to alteration of cellular homeostasis or defective repair of ROS-induced damage lies at the root of diseases characterized by both neurodegeneration and bone marrow failure as well as cancer. That these diseases may be reflective of the dynamic ability of cells to respond to ROS through developmental stages and aging lies in the similarities between phenotypes at the cellular level. This review summarizes work linking the ability to regulate intracellular ROS to the hematopoietic stem cell phenotype, aging, and disease.

20 April 2015 in Nucleic Acid Therapeutics
Verified
Journal Article
Closed access
GBGregory Benedetto
Gregory Benedetto
THTimothy J. Hamp
Timothy J. Hamp
PWPeter J. Wesselman
Peter J. Wesselman
CRChristine Richardson
Christine Richardson
Ovarian cancer is often diagnosed in late stages with few treatment options and poor long-term prognosis. New clinical tools for early detection of ovarian malignancies will significantly help reduce mortality and improve current long-term survival rates. The objective of this work was to identify ovarian tumor-specific single-stranded DNA aptamers that bind to malignant ovarian tumor cells and internalize with high affinity and specificity. Aptamers can identify unique tumor biomarkers, can aid in early detection and diagnosis of neoplastic disorders, and can be functionalized by conjugation to small molecules. To identify aptamers from random single-stranded DNA pools (60 bases long), we used whole Cell-SELEX (systematic evolution of ligands by exponential enrichment) to enrich and isolate tumor-specific aptamers that bind to tumor-specific receptors in their native state on the cell surface. Next-Generation sequencing identified seven novel aptamers and detailed analyses of three are described. Aptamers bound to, and were internalized by, target Caov-3 cell populations, but not nontarget nonmalignant ovarian epithelial HOSE 6-3 cells or multiple other epithelial tumor cell lines. Furthermore, aptamers showed unique binding affinities with apparent dissociation constants ( K d ) measuring in the submicromolar range supporting their physiological relevance and potential use in clinical applications.


1 January 2020 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
DGDonna Goodenow
Donna Goodenow
FEFaith Emmanuel
Faith Emmanuel
CBChase Berman
Chase Berman
MSMark Sahyouni
Mark Sahyouni
CRChristine Richardson
Christine Richardson

2 November 2018 in Environmental and Molecular Mutagenesis
Verified
Journal Article
Closed access
PDF file
BBBhawana Bariar
Bhawana Bariar
CVC. Greer Vestal
C. Greer Vestal
BDBradley Deem
Bradley Deem
DGDonna Goodenow
Donna Goodenow
MUMimi Ughetta
Mimi Ughetta
CRChristine Richardson
Christine Richardson

19 May 2021
Verified
Book Chapter
Open access
PDF file
DGDonna Goodenow
Donna Goodenow
KLKiran Lalwani
Kiran Lalwani
CRChristine Richardson
Christine Richardson
Eukaryotic cells use homologous recombination (HR), classical end-joining (C-NHEJ), and alternative end-joining (Alt-EJ) to repair DNA double-strand breaks (DSBs). Repair pathway choice is controlled by the activation and activity of pathways specific proteins in eukaryotes. Activity may be regulated by cell cycle stage, tissue type, and differentiation status. Bioflavonoids and other environmental agents such as pesticides have been shown to biochemically act as inhibitors of topoisomerase II (Top2). In cells, bioflavonoids directly lead to DNA double-strand breaks through both Top2-dependent and independent mechanisms, as well as induce DNA damage response (DDR) signaling, and promote alternative end-joining and chromosome alterations. This chapter will present differences in expression and activity of proteins in major DNA repair pathways, findings of Top2 inhibition by bioflavonoids and cellular response, discuss how these compounds trigger alternative end-joining, and conclude with implications for genome instability and human disease.